Full Name
Chevon Rariy, MD
Job Title
Chief Clinical Innovation Officer
Company
Visana Health
Speaker Bio
Chevon Rariy, M.D. is a physician-executive and healthcare innovator dedicated to transforming care delivery through technology, data-driven insights, and value-based models that drive better outcomes, elevate patient experience, and improve cost efficiency. As Chief Clinical Innovation Officer at Visana Health, she leads clinical strategy and innovation to expand virtual-first, evidence-based care across gynecology, hormonal health, and comorbid chronic conditions—including weight management, hypertension, diabetes, and thyroid disorders—advancing a more comprehensive women’s health model. Dr. Rariy drives cross-functional collaboration across clinical care, product, technology, data science, and commercial strategy to optimize virtual, personalized, high-quality care delivery at scale.
Previously, Dr. Rariy was the Chief Health Officer at Oncology Care Partners, where she spearheaded the digital transformation of a value-based oncology network, leveraging technology to enhance patient experience, improve clinical quality, and lower costs. Before that, she served as Chief Medical Officer, Clinical Strategy, within the care delivery arm of Amazon Care, playing a pivotal role in developing and expanding Amazon’s national primary care telehealth platform. She was also a Venture Partner at Takeda Digital Ventures, advising on investments at the intersection of healthcare and technology, and has held senior executive roles across government, academia, and private medical centers.
A recognized thought leader, Dr. Rariy has been honored with the Modern Healthcare Innovator Award (2024) and named among Becker’s Black Leaders in Healthcare (2024). Her research has been published in The New England Journal of Medicine, and her work has been featured in Fortune, Healthcare IT News, and leading industry conferences, including HLTH, ATA, and ViVE.
Dr. Rariy is a member of the FDA Digital Health Advisory Committee, providing guidance on AI/ML in medicine, virtual reality, decentralized clinical trials, and cybersecurity. She also serves as an advisor and board member for nonprofit and private healthcare organizations.
Board-certified in both Internal Medicine and Endocrinology, Dr. Rariy completed her fellowship training at Harvard Medical School’s Brigham and Women’s Hospital and the University of Pittsburgh Medical Center (UPMC). She earned her medical degree from Harvard Medical School.
Previously, Dr. Rariy was the Chief Health Officer at Oncology Care Partners, where she spearheaded the digital transformation of a value-based oncology network, leveraging technology to enhance patient experience, improve clinical quality, and lower costs. Before that, she served as Chief Medical Officer, Clinical Strategy, within the care delivery arm of Amazon Care, playing a pivotal role in developing and expanding Amazon’s national primary care telehealth platform. She was also a Venture Partner at Takeda Digital Ventures, advising on investments at the intersection of healthcare and technology, and has held senior executive roles across government, academia, and private medical centers.
A recognized thought leader, Dr. Rariy has been honored with the Modern Healthcare Innovator Award (2024) and named among Becker’s Black Leaders in Healthcare (2024). Her research has been published in The New England Journal of Medicine, and her work has been featured in Fortune, Healthcare IT News, and leading industry conferences, including HLTH, ATA, and ViVE.
Dr. Rariy is a member of the FDA Digital Health Advisory Committee, providing guidance on AI/ML in medicine, virtual reality, decentralized clinical trials, and cybersecurity. She also serves as an advisor and board member for nonprofit and private healthcare organizations.
Board-certified in both Internal Medicine and Endocrinology, Dr. Rariy completed her fellowship training at Harvard Medical School’s Brigham and Women’s Hospital and the University of Pittsburgh Medical Center (UPMC). She earned her medical degree from Harvard Medical School.
Speaking At